Chad K. Oh
Chief Medical OfficerDr. Chad K. Oh, M.D., serves as a Chief Medical Officer at AEON Biopharma, Inc., since June 09, 2021. Dr. Oh lead the company’s clinical development of ABP-450, which includes a Phase 2 clinical study for the treatment of cervical dystonia and a Phase 2 clinical study for the preventive treatment of migraine. Dr. Oh has combined experience in academia and the pharmaceutical industry, with a concentration in clinical development of various therapeutic areas, including CNS, infectious diseases, respiratory diseases, cancer, autoimmune diseases and rare/orphan diseases. He has effectively led multiple submissions to the U.S., European and Asian regulatory authorities, including over 30 IND submissions, 20 505(b)(2) submissions, completed three NDAs and completed one BLA. He served as the Vice President for the Propharma Group from August 2018 to June 2021. From January 2017 to January 2018, Dr. Oh served as Vice President of Clinical Development for Revance Therapeutics. Dr. Oh has held various positions, including as Medical Director and as Vice President, for a number of biotechnology and pharmaceutical companies with a specific concentration in clinical development of certain therapeutic areas, including autoimmune diseases, respiratory diseases, CNS, oncology and rare orphan diseases from 2008 to 2017. Dr. Oh is board-certified in Allergy and Immunology and Pediatrics and served as the Chief of Allergy & Immunology at the UCLA-Harbor Medical Center from 1995 to 2008. He completed a research fellowship in neurology at Northwestern University, School of Medicine in Chicago, residency in pediatrics at Rush-Presbyterian-St Luke’s Medical Center in Chicago and a clinical fellowship in allergy and immunology at the National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland. He is an author of approximately 70 peer-reviewed publications, book chapters and review articles, as well as over 70 published abstracts and inventor or co-inventor of multiple patents. Dr. Oh received his M.D. from the Kyung-Hee University School of Medicine, Seoul, South Korea.
公司職務
- 公司名稱AEON Biopharma, Inc.股票代碼AEON職務Chief Medical Officer共事同僚
- RBRobert BancroftPresident, CEO & Director
- JFJost FischerIndependent Chairman
- AWAlex WilsonChief Legal & Strategy Officer and Corporate Secretary
- JAJohn A. BencichChief Financial Officer
- JSJennifer SyChief Accounting Officer
- SBShelley B. ThunenIndependent Director
- RJRobert J. PalmisanoIndependent Director
- MFMarc ForthDirector
